Bank of America’s Immunome IMNM Stock Holding History
Bought
Maintained
Sold
Other funds holding IMNM
RG
VCM
DCM
ES
Bank of America's IMNM Position: Q1 2026 in Review
Bank of America increased its Immunome (IMNM) stake by 286% in Q1 2026, buying an estimated $12.9M and bringing the position to 781,607 shares worth $17.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2533.
Bank of America first reported a position in IMNM in Q4 2020 and has held it in 15 quarters since. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.
- Bank of America held 781,607 shares of Immunome worth $17.1M as of Q1 2026.
- Bank of America bought 578,890 Immunome shares in Q1 2026, an estimated $12.9M.
- Immunome made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #2533 holding.
- Bank of America first reported a position in Immunome in Q4 2020 and has held it in 15 quarters since.
- 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.